Systemic exertion intolerance disease associated to neuroendocrine dysfunction and cortical atrophy: a case report.

BACKGROUND: Scarce evidence about the organic and functional abnormalities of systemic exertion intolerance disease (SEID) is found in literature and the pathophysiology is still unclear. METHODS: Following the CARE Guidelines, this case report describes a patient with a 5-year history of nonspecific symptoms, lately recognized as SEID. RESULTS: Low serum thyroid- and adrenocorticotropic stimulating hormone levels, and 24-h urinary cortisol excretion almost twice the upper limit were detected. Computed tomography scan found significant cortical atrophy. Low-dose modafinil improved the clinical outcome, added to nonpharmacologic approach. CONCLUSION: To ascertain an accurate SEID diagnosis and treatment are a challenge in daily clinical practice, that must be engaged based in clear methods and good practice recommendations. Thus, family practitioners should be aware of this diagnosis.

Possible Application of Melatonin in Long COVID.

Clinical sequelae and symptoms for a considerable number of COVID-19 patients can linger for months beyond the acute stage of SARS-CoV-2 infection, "long COVID". Among the long-term consequences of SARS-CoV-2 infection, cognitive issues (especially memory loss or "brain fog"), chronic fatigue, myalgia, and muscular weakness resembling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are of importance. Melatonin may be particularly effective at reducing the signs and symptoms of SARS-CoV-2 infection due to its functions as an antioxidant, anti-inflammatory, and immuno-modulatory agent. Melatonin is also a chronobiotic medication effective in treating delirium and restoring the circadian imbalance seen in COVID patients in the intensive care unit. Additionally, as a cytoprotector, melatonin aids in the prevention of several COVID-19 comorbidities, including diabetes, metabolic syndrome, and ischemic and non-ischemic cardiovascular diseases. This narrative review discusses the application of melatonin as a neuroprotective agent to control cognitive deterioration ("brain fog") and pain in the ME/CFS syndrome-like documented in long COVID. Further studies on the therapeutic use of melatonin in the neurological sequelae of SARS-CoV-2 infection are warranted.

Post-viral fatigue in COVID-19: A review of symptom assessment methods, mental, cognitive, and physical impairment.

Coronavirus 2 is responsible for Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), and the main sequela is persistent fatigue. Post-viral fatigue is common and affects patients with mild, asymptomatic coronavirus disease-2019 (COVID-19). However, the exact mechanisms involved in developing post-COVID-19 fatigue remain unclear. Furthermore, physical and cognitive impairments in these individuals have been widely described. Therefore, this review aims to summarize and propose tools from a multifaceted perspective to assess COVID-19 infection. Herein, we point out the instruments that can be used to assess fatigue in long-term COVID-19: fatigue in a subjective manner or fatigability in an objective manner. For physical and mental fatigue, structured questionnaires were used to assess perceived symptoms, and physical and cognitive performance assessment tests were used to measure fatigability using reduced performance.

Clinical overlap between fibromyalgia and myalgic encephalomyelitis. A systematic review and meta-analysis.

Myalgic encephalomyelitis is an illness characterized by profound malaise after mental or physical effort occurring in patients already suffering from constant fatigue. On the other hand, widespread pain and widespread allodynia are the core fibromyalgia clinical features. There is controversy on these two syndromes alikeness. Through the years, different diagnostic and/or classification criteria have been put forward to appraise both fibromyalgia and myalgic encephalomyelitis. The epidemiology of these two illnesses, and their overlap, may vary accordingly to the used definition. The most recent Wolfe et al. 2016 fibromyalgia diagnostic criteria incorporates three myalgic encephalomyelitis features including fatigue, waking unrefreshed and dyscognition. The objective of this meta-analysis was to define the clinical overlap between fibromyalgia and myalgic encephalomyelitis based on a systematic literature review. METHODS: PubMed, Embase, Lilacs, and Cochrane data bases were searched on January 25, 2021 linking the medical subject heading "Fibromyalgia" to the following terms "chronic fatigue syndrome", "myalgic encephalomyelitis" and "systemic exertion intolerance disease". Our review included all original articles in which the clinical overlap between fibromyalgia and myalgic encephalomyelitis could be quantified based on recognized diagnostic or classification criteria. Articles scrutiny and selection followed the PRISMA guidelines. Each study quality was assessed according to GRADE recommendations. The global clinical overlap was calculated using a fixed effect model with inverse variance-weighted average method. RESULTS: Twenty one publications were included in the meta-analysis. Reviewed studies were highly dissimilar in their design, objectives, sample size, diagnostic criteria, and/or outcomes yielding a 98% heterogeneity index. Nevertheless, the clinical overlap between fibromyalgia and myalgic encephalomyelitis was a well defined outcome that could be reliably calculated despite the high heterogeneity value. All reviewed publications had moderate GRADE evidence level. Most evaluated articles used the old 1990 Wolfe et al. fibromyalgia diagnostic criteria. Myalgic encephalomyelitis and fibromyalgia diagnoses overlapped in 47.3% (95% CI: 45.97-48.63) of the reported cases. CONCLUSION: This meta-analysis found prominent clinical overlap between fibromyalgia and myalgic encephalomyelitis. It seems likely that this concordance would be even higher when using the most recent Wolfe et al. 2016 fibromyalgia diagnostic criteria.

O metabolismo energético mitocondrial e a síndrome da fadiga crônica: uma scoping review / The mitochondrial energy metabolism and chronic fatigue syndrome: a scoping review

Nessa dissertação foi realizada uma scoping review com objetivo de buscar na literatura o que existe, até o presente momento, para explicar a relação entre o metabolismo mitocondrial com a síndrome da fadiga crônica (SFC). A SFC se apresenta de forma diferente para cada indivíduo, o que torna complexo seu entendimento, uma vez que não foram identificados biomarcadores específicos para auxiliar em um diagnóstico definitivo que favoreça uma intervenção adequada e tratamentos mais eficazes. Diferentes mecanismos biológicos são estudados, sendo que alterações no metabolismo mitocondrial têm sido foco de pesquisas recentes. Tais alterações podem ser a causa de fadiga severa e estudos sobre SFC mostraram que entre os principais indicadores da disfunção mitocondrial, envolvidos com a menor produção de ATP, está o comprometimento das vias de fosforilação oxidativa. O método utilizado nessa revisão, scoping review, é utilizado para investigar conceitos-chave subjacentes a uma nova área de pesquisa, bem como esclarecer definições de trabalhos, analisando o título e resumo de artigos para seleciona-los. Como critérios de inclusão ficaram determinados: (1) estudos clínicos que registram pacientes adultos (>= 18 anos de idade); (2) mostram uma relação entre questões do metabolismo e bioenergética mitocondrial com síndrome da fadiga crônica; (3) são escritos em português, inglês ou espanhol; (4) artigos publicados nos últimos 10 anos. E de exclusão: (1) utilizaram modelos animai; (2) relatos de casos, editoriais, cartas, revisões de literatura, resumos e dissertações de reuniões; (3) literatura cinzenta. Entre os descritores comuns, utilizados para realizar a busca nas bases de dados estão: mitochondria OR mitochondrial, fatigue, bioenergy OR bioenergetic OR energy metabolism. O estudo foi guiado pela seguinte questão: ""Alterações no metabolismo energético mitocondrial estão relacionados com a origem e prevalência da síndrome da fadiga crônica?". Após utilizar a estratégia de busca, específica para cada uma das quatro bases de dados (PubMed, EMBASE, SCOPUS e Web of Science), foram encontrados 228 artigos, os quais foram exportados para o software Rayyan QCRI e removidos aqueles que se encontravam em duplicata. Este software permitiu que dois revisores executassem, de forma independente, a leitura dos títulos e resumos de 150 artigos e 27 foram selecionados para a leitura na íntegra, por atenderem aos critérios supracitados. Dentre esses últimos, apenas 10 relatavam alterações no metabolismo mitocondrial relacionadas à SFC. As alterações compreendem modificações nas vias de transporte mitocondrial e na cadeia respiratória; mutações no DNA mitocondrial e, até mesmo, disfunções energéticas em células do sistema imune, como as natural-killer. Foram encontrados dados de pesquisas em diversas áreas clínicas, tais como: cardiologia, oncologia e distúrbios musculares, os quais podem colaborar para trazer luz às causas biológicas dessa síndrome. Desta forma, tornou-se ainda mais evidente a conexão entre distúrbios na bioenergética mitocondrial, como uma menor capacidade de transporte de oxigênio por meio das vias de transporte, ou até mesmo, a insuficiência mitocondrial para produção de ATP, com a SFC. De acordo com os estudos que compuseram a amostra final desta revisão (n=10), o metabolismo mitocondrial e suas principais atividades, como a produção e transporte de ATP, são um alvo potencial para auxiliar na compreensão de incógnitas existentes sobre a SFC. Esses resultados são promissores para a enfermagem, sobretudo na área da ciência dos sintomas, com impacto na qualidade de vida e no manejo personalizado de sintomas em diferentes condições crônicas, especialmente na SFC

In this dissertation a scoping review was carried out with the objective of searching in the literature what exists to date to explain the relationship between mitochondrial metabolism and chronic fatigue syndrome (CFS). SFC presents itself differently for each individual, which makes complex their understanding, since no specific biomarkers were identified to aid in a definitive diagnosis that favors an appropriate intervention and more effective treatments. Different biological mechanisms are studied, and changes in mitochondrial metabolism have been the focus of recent research. Such alterations may be the cause of severe fatigue and studies on CFS have shown that among the main indicators of mitochondrial dysfunction, involved in the lower production of ATP, is the involvement of oxidative phosphorylation pathways. The method used in this review, scoping review, is used to investigate key concepts underlying a new research area, as well as clarifying definitions of papers, analyzing the title and abstract articles to select them. As inclusion criteria were determined: (1) clinical studies that register adult patients (>= 18 years of age); (2) show a relationship between metabolism and bioenergetic mitochondrial issues with chronic fatigue syndrome; (3) written in Portuguese, English or Spanish; (4) articles published in the last 10 years. The exclusion criteria: (1) used animal models; (2) case reports, editorials, letters, literature reviews, abstracts and dissertations; (3) gray literature. Among the common descriptors used to perform the search in the databases are: mitochondria OR mitochondrial, fatigue, bioenergy OR bioenergetic OR energy metabolism. The study was guided by the following question: "" Changes in mitochondrial energy metabolism are related to the origin and prevalence of chronic fatigue syndrome? ". After using the search strategy, specific to each of the four databases (PubMed, EMBASE, SCOPUS and Web of Science), 228 articles were found, which were exported to the Rayyan QCRI software and removed from those that were in duplicate. This software allowed two reviewers to independently perform the reading of the titles and abstracts of 150 articles and 27 were selected for reading in full, because they meet the aforementioned criteria. Among the latter, only 10 reported changes in mitochondrial metabolism related to CFS. The changes comprise modifications in mitochondrial transport pathways and respiratory chain; mutations in mitochondrial DNA, and even energy dysfunctions in cells of the immune system, such as natural killer. Research data have been found in several clinical areas, such as: cardiology, oncology and muscular disorders, which can collaborate to bring light to the biological causes of this syndrome. Thus, the connection between disturbances in mitochondrial bioenergetics, such as reduced oxygen transport capacity, or even mitochondrial insufficiency for ATP production, with CFS became even more evident. According to the studies that compose the final sample of this review (n = 10), mitochondrial metabolism and its main activities, such as the production and transport of ATP, are a potential target to aid in the understanding of existing unknowns about CFS. These results are promising for nursing, especially in the area of symptom science, with an impact on quality of life and personalized management of symptoms in different chronic conditions, especially CFS

Síndrome de fatiga / Fatigue syndrome

ResumenEl síndrome de fatiga crónica es una patología que se caracteriza por fatiga intensa de como mínimo seis meses de duración, que se acompaña de otros síntomas y que en ocasiones podría ser tan intenso que causa la disminución de las actividades cotidianas del individuo que lo padece. El comienzo de los síntomas puede ser repentino o también de forma paulatina, muchas veces las personas recuerdan el momento en que comenzó y el principio de estos puede ser un cuadro similar a una gripe. A continuación, se hará una revisión bibliográfica sobre los principales aspectos de esta enfermedad, causa, criterios diagnósticos y tratamiento.

AbstractChronic fatigue syndrome is a pathology characterized by intense fatigue of at least six months duration, which is accompanied by other symptoms and which at times could be so intense that it causes the daily activities of the individual suffering from it to diminish. The onset of symptoms may be sudden or also gradually, many times people remember the time they started and the beginning of these can be a flu-like four. Next, a bibliographic review will be done on the main aspects of this disease, cause, diagnostic criteria and treatment.

Mindfulness-Based Stress Reduction for Adolescents with Functional Somatic Syndromes: A Pilot Cohort Study.

OBJECTIVE: To assess the feasibility of a mindfulness-based stress reduction (MBSR) program for adolescents with widespread chronic pain and other functional somatic symptoms and to make preliminary assessments of its clinical utility. STUDY DESIGN: Three cohorts of subjects completed an 8-week MBSR program. Child- and parent-completed measures were collected at baseline and 8 and 12 weeks later. Measures included the Functional Disability Inventory (FDI), the Fibromyalgia/Symptom Impact Questionnaire-Revised (FIQR/SIQR), the Pediatric Quality of Life Inventory, the Multidimensional Anxiety Scale (MASC2), and the Perceived Stress Scale. Subjects and parents were interviewed following the program to assess feasibility. RESULTS: Fifteen of 18 subjects (83%) completed the 8-week program. No adverse events occurred. Compared with baseline scores, significant changes were found in mean scores on the FDI (33% improvement, P = .026), FIQR/SIQR (26% improvement, P = .03), and MASC2 (child: 12% improvement, P = .02; parent report: 17% improvement, P = .03) at 8 weeks. MASC2 scores (child and parent) and Perceived Stress Scale scores were significantly improved at 12 weeks. More time spent doing home practice was associated with better outcomes in the FDI and FIQR/SIQR (44% and 26% improvement, respectively). Qualitative interviews indicated that subjects and parents reported social support as a benefit of the MBSR class, as well as a positive impact of MBSR on activities of daily living, and on pain and anxiety. CONCLUSIONS: MBSR is a feasible and acceptable intervention in adolescents with functional somatic syndromes and has preliminary evidence for improving functional disability, symptom impact, and anxiety, with consistency between parent and child measures. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02190474.

Adrenal fatigue does not exist: a systematic review.

BACKGROUND: The term "adrenal fatigue" ("AF") has been used by some doctors, healthcare providers, and the general media to describe an alleged condition caused by chronic exposure to stressful situations. Despite this, "AF" has not been recognized by any Endocrinology society, who claim there is no hard evidence for the existence. The aim of this systematic review is to verify whether there is substantiation for "AF". METHODS: A systematic search was performed at PUBMED, MEDLINE (Ebsco) and Cochrane databases, from the beginning of the data until April 22nd, 2016. Searched key words were: "adrenal" + "fatigue", "adrenal" + "burnout", "adrenal" + "exhaustion", "hypoadrenia", "burnout" + "cortisol", "fatigue" + "cortisol", "clinical" + "burnout", "cortisol" + "vitalility", "adrenal" + "vitality", and "cortisol" + "exhaustion". Eligibility criteria were: (1) articles written in English, (2) cortisol profile and fatigue or energy status as the primary outcome, (3) performed tests for evaluating the adrenal axis, (4) absence of influence of corticosteroid therapy, and (5) absence of confounding diseases. Type of questionnaire to distinct fatigued subjects, population studied, tests performed of selected studies were analyzed. RESULTS: From 3,470 articles found, 58 studies fulfilled the criteria: 33 were carried in healthy individuals, and 25 in symptomatic patients. The most assessed exams were "Direct Awakening Cortisol" (n = 29), "Cortisol Awakening Response" (n = 27) and "Salivary Cortisol Rhythm" (n = 26). DISCUSSION: We found an almost systematic finding of conflicting results derived from most of the studies methods utilized, regardless of the validation and the quality of performed tests. Some limitations of the review include: (1) heterogeneity of the study design; (2) the descriptive nature of most studies; (3) the poor quality assessment of fatigue; (4) the use of an unsubstantiated methodology in terms of cortisol assessment (not endorsed by endocrinologists); (5) false premises leading to an incorrect sequence of research direction; and, (6) inappropriate/invalid conclusions regarding causality and association between different information. CONCLUSION: This systematic review proves that there is no substantiation that "adrenal fatigue" is an actual medical condition. Therefore, adrenal fatigue is still a myth.

[Neuroimaging and the case of chronic fatigue syndrome]. / Imagens cerebrais e o caso da síndrome da fadiga crônica.

This article analyzes the use of neuroimaging in research into chronic fatigue syndrome. It reviews some works published in the 1990 s and investigates a specific aspect of these studies, namely the search for a cerebral abnormality, in the form of an altered activation pattern, which could provide a pattern for diagnosis and treatment of the disease. The understanding of chronic fatigue syndrome as a disease reduced to some cerebral findings is analyzed, arguing in favor of a broader vision of this disease that includes psychosocial elements of the patient's life as opposed to entirely somatic explanations.

Imagens cerebrais e o caso da síndrome da fadiga crônica / Neuroimaging and the case of chronic fatigue syndrome

Este artigo analisa o uso de neuroimageamento nas pesquisas da síndrome da fadiga crônica. Revisam-se alguns dos estudos publicados sobre o assunto na década de 1990 e analisa-se um ponto específico desses estudo, que é a busca de alterações na ativação cerebral ou outros tipos de anormalidade que possam fornecer um padrão para diagnóstico e tratamento da doença. Analisa-se o entendimento da síndrome da fadiga crônica como uma doença reduzida aos achados cerebrais, argumentando em favor de uma visão mais ampliada da doença, que leve em conta os elementos psicossociais da vida do paciente em detrimento de explicações reduzidas ao somático.

This article analyzes the use of neuroimaging in research into chronic fatigue syndrome. It reviews some works published in the 1990s and investigates a specific aspect of these studies, namely the search for a cerebral abnormality, in the form of an altered activation pattern, which could provide a pattern for diagnosis and treatment of the disease. The understanding of chronic fatigue syndrome as a disease reduced to some cerebral findings is analyzed, arguing in favor of a broader vision of this disease that includes psychosocial elements of the patient's life as opposed to entirely somatic explanations.

[The chronic asthenia syndrome: a clinical approach]. / Enfoque del síndrome de astenia crónica.

The term asthenia comes from the Greek (centsqsneia, a: privation, without; esthénos: vigor, force), it means absence of strength, vigor or force. It is a symptom, difficult to define, with a set of vague sensations, different for each patient. It is a frequent cause of consult, almost 30% in ambulatory settings. The chronic fatigue represents up to 10% of these cases, and the 0.2-0.7% belongs to the chronic fatigue syndrome. It is very important to differentiate asthenia from weakness, dizziness or dyspnoea, since patients may confuse them. The factor time in asthenia is very useful for its characterization, it was defined to the prolonged fatigue when it lasts for more than a month and chronic when the duration is greater than 6 months. The depression is the commonest fatigue cause, representing approximately half of the cases. The most effective treatment of the asthenia is to solve the underlying cause, although up to 20% of the patients remain without diagnosis. The diagnosis of the chronic fatigue syndrome is of exclusion and the criteria of the international consensus of year 1994 are due to use. The high frequency of the symptom entails an enormous social and economic cost and it is for that reason so important for physicians to have a correct manage of this symptom.

Prevalence of fibromyalgia in a low socioeconomic status population.

BACKGROUND: The aim of this study was to estimate the prevalence of fibromyalgia, as well as to assess the major symptoms of this syndrome in an adult, low socioeconomic status population assisted by the primary health care system in a city in Brazil. METHODS: We cross-sectionally sampled individuals assisted by the public primary health care system (n = 768, 35-60 years old). Participants were interviewed by phone and screened about pain. They were then invited to be clinically assessed (304 accepted). Pain was estimated using a Visual Analogue Scale (VAS). Fibromyalgia was assessed using the Fibromyalgia Impact Questionnaire (FIQ), as well as screening for tender points using dolorimetry. Statistical analyses included Bayesian Statistics and the Kruskal-Wallis Anova test (significance level = 5%). RESULTS: From the phone-interview screening, we divided participants (n = 768) in three groups: No Pain (NP) (n = 185); Regional Pain (RP) (n = 388) and Widespread Pain (WP) (n = 106). Among those participating in the clinical assessments, (304 subjects), the prevalence of fibromyalgia was 4.4% (95% confidence interval [2.6%; 6.3%]). Symptoms of pain (VAS and FIQ), feeling well, job ability, fatigue, morning tiredness, stiffness, anxiety and depression were statically different among the groups. In multivariate analyses we found that individuals with FM and WP had significantly higher impairment than those with RP and NP. FM and WP were similarly disabling. Similarly, RP was no significantly different than NP. CONCLUSION: Fibromyalgia is prevalent in the low socioeconomic status population assisted by the public primary health care system. Prevalence was similar to other studies (4.4%) in a more diverse socioeconomic population. Individuals with FM and WP have significant impact in their well being.

Comparative epidemiology of chronic fatigue syndrome in Brazilian and British primary care: prevalence and recognition.

BACKGROUND: Although fatigue is a ubiquitous symptom across countries, clinical descriptions of chronic fatigue syndrome have arisen from a limited number of high-income countries. This might reflect differences in true prevalence or clinical recognition influenced by sociocultural factors. AIMS: To compare the prevalence, physician recognition and diagnosis of chronic fatigue syndrome in London and São Paulo. METHOD: Primary care patients in London (n=2459) and São Paulo (n=3914) were surveyed for the prevalence of chronic fatigue syndrome. Medical records were reviewed for the physician recognition and diagnosis. RESULTS: The prevalence of chronic fatigue syndrome according to Centers for Disease Control 1994 criteria was comparable in Britain and Brazil: 2.1% v. 1.6% (P=0.20). Medical records review identified 11 diagnosed cases of chronic fatigue syndrome in Britain, but none in Brazil (P<0.001). CONCLUSIONS: The primary care prevalence of chronic fatigue syndrome was similar in two culturally and economically distinct nations. However, doctors are unlikely to recognise and label chronic fatigue syndrome as a discrete disorder in Brazil. The recognition of this illness rather than the illness itself may be culturally induced.

'Physical or psychological?'- a comparative study of causal attribution for chronic fatigue in Brazilian and British primary care patients.

OBJECTIVE: Causal attribution influences symptom experience, help-seeking behaviour and prognosis in chronic fatigue syndrome. We compared causal attribution of patients with unexplained chronic fatigue (UCF) in Brazil and Britain. METHOD: Primary care attenders in São Paulo (n = 3914) and London (n = 2459) were screened for the presence of UCF. Those with UCF (São Paulo n = 452; London n = 178) were assessed for causal attribution (physical vs. psychosocial), perceived chronicity (i.e. reported duration of fatigue) and disability. RESULTS: British UCF patients were more likely to attribute their fatigue to physical causes (adjusted odds ratio 1.70, P = 0.037) and perceived their fatigue to be more chronic (adjusted beta 0.15, P = 0.002). There was no significant difference in current disability (adjusted beta -0.01, P = 0.81). CONCLUSION: Despite similar disability levels, UCF patients in different cultural settings presented different attributions and perceptions about their illness. Sociocultural factors may have an important role in shaping illness attribution and perception around chronic fatigue.

The awareness of chronic fatigue syndrome: a comparative study in Brazil and the United Kingdom.

OBJECTIVE: While in many Western affluent countries there is widespread awareness of chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), little is known about the awareness of CFS/ME in low- and middle-income countries. We compared the awareness of CFS in Brazil and the United Kingdom. METHODS: Recognition and knowledge of CFS were assessed among 120 Brazilian specialist doctors in two major university hospitals using a typical case vignette of CFS. We also surveyed 3914 and 2435 consecutive attenders in Brazilian and British primary care clinics, respectively, concerning their awareness of CFS. RESULTS: When given a typical case vignette of CFS, only 30.8% [95% confidence interval (CI), 22.7-39.9%] of Brazilian specialist doctors mentioned chronic fatigue or CFS as a possible diagnosis, a proportion substantially lower than that observed in Western affluent countries. Similarly, only 16.2% (95% CI, 15.1-17.4%) of Brazilian primary care attenders were aware of CFS, in contrast to 55.1% (95% CI, 53.1-57.1%) of their British counterparts (P<.001). This difference remained highly significant after controlling for patients' sociodemographic and socioeconomic characteristics (P<.001). CONCLUSIONS: The awareness of CFS was substantially lower in Brazil than the United Kingdom. The observed difference may influence patients' help-seeking behavior and both doctors' and patients' beliefs and attitudes in relation to fatigue-related syndromes. Attempts to promote the awareness of CFS should be considered in Brazil, but careful plans are required to ensure the delivery of sound evidence-based information.

Síndrome de fatiga crónica / Chronic fatigue syndrome

El síndrome de fatiga crónica es un trastorno frecuente caracterizado por fatiga persistente y debilitante, que no mejora con el descanso, de al menos seis meses de duración y que, generalmente se acompaña de otros síntomas. Su etiología es desconocida y su diagnóstico requiere la exclusión de otras patologías. El tratamiento no esta firmemente establecido; según la evidencia actual las psicoterapias conductuales y las terapias físicas con ejercicios graduados son los tratamientos que aportarían mas beneficiosos, resultando importante considerar el manejo individualizado y sintomático.

Chronic Fatigue Syndrome is a common disorder characterized by persistent and debilitating fatigue that does not improve withrest, at least six months' duration, usually accompanied by other symptoms. Its etiology is unknown and its diagnosis requiresthe exclusion of other pathologies. The treatment is not firmly established, according to the current evidence behavioralpsychotherapies and graduate exercise's physical therapies are contributing more beneficial treatments. It is importantto consider a symptomatic and individualized management.